Primary Sclerosing Cholangitis

Overview

Journal N Engl J Med

Specialty General Medicine

Date 2016 Sep 23

PMID 27653566

Citations 195

Authors

Konstantinos N Lazaridis

Nicholas F LaRusso

Affiliations

Soon will be listed here.

Citing Articles

Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot study.

Elzubeir A, High J, Hammond M, Shepstone L, Pond M, Walmsley M BMJ Open Gastroenterol. 2025; 12(1).

PMID: 40032516 PMC: 11877274. DOI: 10.1136/bmjgast-2024-001596.

Gallbladder-derived retinoic acid signalling drives reconstruction of the damaged intrahepatic biliary ducts.

He J, Li S, Yang Z, Ma J, Qian C, Huang Z Nat Cell Biol. 2025; 27(1):39-47.

PMID: 39779943 DOI: 10.1038/s41556-024-01568-8.

Recent advances in the role of mesenchymal stem cells as modulators in autoinflammatory diseases.

Chen B, Chen Z, He M, Zhang L, Yang L, Wei L Front Immunol. 2025; 15:1525380.

PMID: 39759531 PMC: 11695405. DOI: 10.3389/fimmu.2024.1525380.

Anti-integrin αvβ6 Antibodies Predict Pouchitis in Patients With Ulcerative Colitis After Restorative Proctocolectomy With Ileal Pouch-Anal Anastomosis.

Nakanishi R, Kuwada T, Shiokawa M, Nishikawa Y, Ota S, Yamazaki H Inflamm Bowel Dis. 2024; 31(3):777-785.

PMID: 39657162 PMC: 11890122. DOI: 10.1093/ibd/izae263.

Racial Disparities in Inpatient Hospital Outcomes of Primary Sclerosing Cholangitis in United States: Nationwide Analysis.

Vohra I, Gopakumar H, Dahiya D, Kahaleh M, Sharma N Diagnostics (Basel). 2024; 14(22).

PMID: 39594159 PMC: 11592423. DOI: 10.3390/diagnostics14222493.

References

Lindor K, Kowdley K, Harrison M . ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol. 2015; 110(5):646-59. DOI: 10.1038/ajg.2015.112. View

Ponsioen C, Chapman R, Chazouilleres O, Hirschfield G, Karlsen T, Lohse A . Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process. Hepatology. 2015; 63(4):1357-67. DOI: 10.1002/hep.28256. View

Razumilava N, Gores G . Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol. 2012; 11(1):13-21.e1. PMC: 3596004. DOI: 10.1016/j.cgh.2012.09.009. View

Melum E, Franke A, Schramm C, Weismuller T, Gotthardt D, Offner F . Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet. 2010; 43(1):17-9. PMC: 4354850. DOI: 10.1038/ng.728. View

Hirschfield G, Karlsen T, Lindor K, Adams D . Primary sclerosing cholangitis. Lancet. 2013; 382(9904):1587-99. DOI: 10.1016/S0140-6736(13)60096-3. View

Miethke A, Zhang W, Simmons J, Taylor A, Shi T, Shanmukhappa S . Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice. Hepatology. 2015; 63(2):512-23. PMC: 4713368. DOI: 10.1002/hep.27973. View

Lewis J, Talwalkar J, Rosen C, Smyrk T, Abraham S . Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Am J Surg Pathol. 2007; 31(6):907-13. DOI: 10.1097/01.pas.0000213435.99492.8a. View

Angulo P, Grandison G, Fong D, Keach J, Lindor K, Bjornsson E . Bone disease in patients with primary sclerosing cholangitis. Gastroenterology. 2010; 140(1):180-8. PMC: 3043598. DOI: 10.1053/j.gastro.2010.10.014. View

Naess S, Lie B, Melum E, Olsson M, Hov J, Croucher P . Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population. PLoS One. 2014; 9(12):e114486. PMC: 4270690. DOI: 10.1371/journal.pone.0114486. View

10.

Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D . A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl. 2009; 15(3):330-40. DOI: 10.1002/lt.21679. View

11.

Lindor K, Kowdley K, Luketic V, Harrison M, McCashland T, Befeler A . High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology. 2009; 50(3):808-14. PMC: 2758780. DOI: 10.1002/hep.23082. View

12.

Mamari S, Djordjevic J, Halliday J, Chapman R . Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol. 2012; 58(2):329-34. DOI: 10.1016/j.jhep.2012.10.013. View

13.

Boonstra K, Weersma R, van Erpecum K, Rauws E, Spanier B, Poen A . Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013; 58(6):2045-55. DOI: 10.1002/hep.26565. View

14.

Mueller T, Beutler C, Pico A, Shibolet O, Pratt D, Pascher A . Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis. Liver Int. 2011; 31(10):1574-88. DOI: 10.1111/j.1478-3231.2011.02635.x. View

15.

Coppe J, Patil C, Rodier F, Sun Y, Munoz D, Goldstein J . Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008; 6(12):2853-68. PMC: 2592359. DOI: 10.1371/journal.pbio.0060301. View

16.

Eksteen B, Grant A, Miles A, Curbishley S, Lalor P, Hubscher S . Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med. 2004; 200(11):1511-7. PMC: 2211943. DOI: 10.1084/jem.20041035. View

17.

Murad S, Kim W, Harnois D, Douglas D, Burton J, Kulik L . Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012; 143(1):88-98.e3. PMC: 3846443. DOI: 10.1053/j.gastro.2012.04.008. View

18.

Angulo P, Lindor K . Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology. 2002; 35(6):1494-500. DOI: 10.1053/jhep.2002.33202. View

19.

Boonstra K, Beuers U, Ponsioen C . Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012; 56(5):1181-1188. DOI: 10.1016/j.jhep.2011.10.025. View

20.

Haruta I, Kikuchi K, Hashimoto E, Nakamura M, Miyakawa H, Hirota K . Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation. Lab Invest. 2010; 90(4):577-88. DOI: 10.1038/labinvest.2010.40. View